Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Environmental exposures such as smoking and low vitamin D are predictive of poor outcome in cutaneous melanoma rather than other deprivation measures.

Hardie CM, Elliott F, Chan M, Rogers Z, Bishop DT, Newton-Bishop JA.

J Invest Dermatol. 2019 Aug 16. pii: S0022-202X(19)32703-4. doi: 10.1016/j.jid.2019.05.033. [Epub ahead of print]

PMID:
31425707
2.

Pathological review of primary cutaneous malignant melanoma by a specialist skin cancer multidisciplinary team improves patient care in the UK.

Bhoyrul B, Brent G, Elliott F, McLorinan J, Wilson A, Peach H, Mathew B, Mitra A.

J Clin Pathol. 2019 Jul;72(7):482-486. doi: 10.1136/jclinpath-2019-205767. Epub 2019 May 14.

PMID:
31088937
3.

Discovery of common and rare genetic risk variants for colorectal cancer.

Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, Greenside P, Wainberg M, Schumacher FR, Smith JD, Levine DM, Nelson SC, Sinnott-Armstrong NA, Albanes D, Alonso MH, Anderson K, Arnau-Collell C, Arndt V, Bamia C, Banbury BL, Baron JA, Berndt SI, Bézieau S, Bishop DT, Boehm J, Boeing H, Brenner H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman A, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castellví-Bel S, Chan AT, Chang-Claude J, Chanock SJ, Chirlaque MD, Cho SH, Connolly CM, Cross AJ, Cuk K, Curtis KR, de la Chapelle A, Doheny KF, Duggan D, Easton DF, Elias SG, Elliott F, English DR, Feskens EJM, Figueiredo JC, Fischer R, FitzGerald LM, Forman D, Gala M, Gallinger S, Gauderman WJ, Giles GG, Gillanders E, Gong J, Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ, Haile RW, Hampe J, Hampel H, Harlid S, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Hsu WL, Huang WY, Hudson TJ, Hunter DJ, Ibañez-Sanz G, Idos GE, Ingersoll R, Jackson RD, Jacobs EJ, Jenkins MA, Joshi AD, Joshu CE, Keku TO, Key TJ, Kim HR, Kobayashi E, Kolonel LN, Kooperberg C, Kühn T, Küry S, Kweon SS, Larsson SC, Laurie CA, Le Marchand L, Leal SM, Lee SC, Lejbkowicz F, Lemire M, Li CI, Li L, Lieb W, Lin Y, Lindblom A, Lindor NM, Ling H, Louie TL, Männistö S, Markowitz SD, Martín V, Masala G, McNeil CE, Melas M, Milne RL, Moreno L, Murphy N, Myte R, Naccarati A, Newcomb PA, Offit K, Ogino S, Onland-Moret NC, Pardini B, Parfrey PS, Pearlman R, Perduca V, Pharoah PDP, Pinchev M, Platz EA, Prentice RL, Pugh E, Raskin L, Rennert G, Rennert HS, Riboli E, Rodríguez-Barranco M, Romm J, Sakoda LC, Schafmayer C, Schoen RE, Seminara D, Shah M, Shelford T, Shin MH, Shulman K, Sieri S, Slattery ML, Southey MC, Stadler ZK, Stegmaier C, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Thomas SS, Toland AE, Trichopoulou A, Ulrich CM, Van Den Berg DJ, van Duijnhoven FJB, Van Guelpen B, van Kranen H, Vijai J, Visvanathan K, Vodicka P, Vodickova L, Vymetalkova V, Weigl K, Weinstein SJ, White E, Win AK, Wolf CR, Wolk A, Woods MO, Wu AH, Zaidi SH, Zanke BW, Zhang Q, Zheng W, Scacheri PC, Potter JD, Bassik MC, Kundaje A, Casey G, Moreno V, Abecasis GR, Nickerson DA, Gruber SB, Hsu L, Peters U.

Nat Genet. 2019 Jan;51(1):76-87. doi: 10.1038/s41588-018-0286-6. Epub 2018 Dec 3.

4.

Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.

Sheth H, Northwood E, Ulrich CM, Scherer D, Elliott F, Barrett JH, Forman D, Wolf CR, Smith G, Jackson MS, Santibanez-Koref M, Haile R, Casey G, Jenkins M, Win AK, Hopper JL, Marchand LL, Lindor NM, Thibodeau SN, Potter JD, Burn J, Bishop DT.

PLoS One. 2018 Feb 9;13(2):e0192223. doi: 10.1371/journal.pone.0192223. eCollection 2018.

5.

Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.

Seligmann JF, Hatch AJ, Richman SD, Elliott F, Jacobs B, Brown S, Hurwitz H, Barrett JH, Quirke P, Nixon AB, Seymour MT.

JAMA Oncol. 2018 Apr 1;4(4):564-568. doi: 10.1001/jamaoncol.2017.3168.

6.

Testing and Inspecting Your Emergency Equipment.

Elliott F.

Occup Health Saf. 2017 May;86(5):19-20.

PMID:
30285329
7.

First Aid Preparedness.

Elliott F.

Occup Health Saf. 2017 Apr;86(4):28, 30.

PMID:
30281967
10.

Do Wellness Tourists Get Well? An Observational Study of Multiple Dimensions of Health and Well-Being After a Week-Long Retreat.

Cohen MM, Elliott F, Oates L, Schembri A, Mantri N.

J Altern Complement Med. 2017 Feb;23(2):140-148. doi: 10.1089/acm.2016.0268. Epub 2017 Jan 9.

11.

A population-based analysis of germline BAP1 mutations in melanoma.

O'Shea SJ, Robles-Espinoza CD, McLellan L, Harrigan J, Jacq X, Hewinson J, Iyer V, Merchant W, Elliott F, Harland M, Bishop DT, Newton-Bishop JA, Adams DJ.

Hum Mol Genet. 2017 Feb 15;26(4):717-728. doi: 10.1093/hmg/ddw403.

12.

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials.

Seligmann JF, Fisher D, Smith CG, Richman SD, Elliott F, Brown S, Adams R, Maughan T, Quirke P, Cheadle J, Seymour M, Middleton G.

Ann Oncol. 2017 Mar 1;28(3):562-568. doi: 10.1093/annonc/mdw645.

13.

Avoid Toxic Gas Exposures.

Elliott F.

Occup Health Saf. 2016 Dec;85(12):8.

PMID:
30289225
14.

Making Sense of a Safety Data Sheet.

Elliott F.

Occup Health Saf. 2016 Nov;85(11):12.

PMID:
30281255
15.

Putting Our Best-Protected Feet Forward.

Elliott F.

Occup Health Saf. 2016 Oct;85(10):16, 18, 20, 22, 24. No abstract available.

PMID:
30280855
16.

Psychosocial, clinical and demographic features related to worry in patients with melanoma.

Rogers Z, Elliott F, Kasparian NA, Bishop DT, Barrett JH, Newton-Bishop J.

Melanoma Res. 2016 Oct;26(5):497-504. doi: 10.1097/CMR.0000000000000266.

17.

Keys to Preventing Eye Injuries.

Elliott F.

Occup Health Saf. 2016 Feb;85(2):24, 27. No abstract available.

PMID:
26983321
18.

Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.

Seligmann JF, Elliott F, Richman SD, Jacobs B, Hemmings G, Brown S, Barrett JH, Tejpar S, Quirke P, Seymour MT.

JAMA Oncol. 2016 May 1;2(5):633-642. doi: 10.1001/jamaoncol.2015.6065.

PMID:
26867820
19.

Understand the Dangers of Electrical Shock.

Elliott F.

Occup Health Saf. 2015 Dec;84(12):36. No abstract available.

PMID:
26742280
20.

First-Class Protection.

Elliott F.

Occup Health Saf. 2015 Sep;84(9):56. No abstract available.

PMID:
26495620
21.

Preventing Manual Handling Injuries.

Elliott F.

Occup Health Saf. 2015 Sep;84(9):18, 20. No abstract available.

PMID:
26495617
22.

Keeping Hand Injuries in Check.

Elliott F.

Occup Health Saf. 2015 Apr;84(4):16, 18-9. No abstract available.

PMID:
26201234
23.

Key considerations for emergency equipment.

Elliott F.

Occup Health Saf. 2015 May;84(5):18-20. No abstract available.

PMID:
26043470
24.

Rules of the road.

Elliott F.

Occup Health Saf. 2014 Nov;83(11):14. No abstract available.

PMID:
25980241
25.

Trachelectomy during pregnancy: what has experience taught us?

Saso S, Sawyer R, O'Neill NM, Tzafetas M, Sayasneh A, Hamed AH, Elliott F, Thum MY, Ghaem-Maghami S, Lee MJ, Smith JR, Del Priore G.

J Obstet Gynaecol Res. 2015 Apr;41(4):640-5. doi: 10.1111/jog.12594. Epub 2014 Nov 25.

PMID:
25420436
26.

New alliance helps with clearing the air.

Elliott F.

Occup Health Saf. 2014 Sep;83(9):48, 50. No abstract available.

PMID:
25272918
27.

The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.

Jewell R, Elliott F, Laye J, Nsengimana J, Davies J, Walker C, Conway C, Mitra A, Harland M, Cook MG, Boon A, Storr S, Safuan S, Martin SG, Jirström K, Olsson H, Ingvar C, Lauss M, Bishop T, Jönsson G, Newton-Bishop J.

Pigment Cell Melanoma Res. 2015 Jan;28(1):94-104. doi: 10.1111/pcmr.12315. Epub 2014 Oct 1.

28.

Point of care testing for improving risk- benefit ratio of aspirin and warfarin.

Sheth H, Northwood E, Elliott F, Jackson M, Koref MS, Tyson J, Daly A, O'Halloran J, Sheth J, Sheth F, Parikh K, Bishop DT, Burn J.

Mol Cytogenet. 2014 Jan 21;7(Suppl 1 Proceedings of the International Conference on Human):I54. doi: 10.1186/1755-8166-7-S1-I54. eCollection 2014. No abstract available.

29.

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy.

Abbotts R, Jewell R, Nsengimana J, Maloney DJ, Simeonov A, Seedhouse C, Elliott F, Laye J, Walker C, Jadhav A, Grabowska A, Ball G, Patel PM, Newton-Bishop J, Wilson DM 3rd, Madhusudan S.

Oncotarget. 2014 May 30;5(10):3273-86.

30.

Inherited variation in the PARP1 gene and survival from melanoma.

Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Sivaramakrishna Rachakonda P, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Timothy Bishop D, Newton-Bishop J.

Int J Cancer. 2014 Oct 1;135(7):1625-33. doi: 10.1002/ijc.28796. Epub 2014 Mar 6.

31.

Footwear in focus.

Elliott F.

Occup Health Saf. 2013 Jul;82(7):15. No abstract available.

PMID:
23951837
32.

Plasma osteopontin concentrations in patients with cutaneous melanoma.

Filia A, Elliott F, Wind T, Field S, Davies J, Kukalizch K, Randerson-Moor J, Harland M, Bishop DT, Banks RE, Newton-Bishop JA.

Oncol Rep. 2013 Oct;30(4):1575-80. doi: 10.3892/or.2013.2666. Epub 2013 Aug 8.

33.

Do vitamin A serum levels moderate outcome or the protective effect of vitamin D on outcome from malignant melanoma?

Field S, Elliott F, Randerson-Moor J, Kukalizch K, Barrett JH, Bishop DT, Newton-Bishop JA.

Clin Nutr. 2013 Dec;32(6):1012-6. doi: 10.1016/j.clnu.2013.04.006. Epub 2013 Apr 13.

PMID:
23669635
34.

Clinicopathologic features of V600E and V600K melanoma--letter.

Jewell R, Chambers P, Harland M, Laye J, Conway C, Mitra A, Elliott F, Cook MG, Boon A, Newton-Bishop J.

Clin Cancer Res. 2012 Dec 15;18(24):6792; author's reply p. 6793. doi: 10.1158/1078-0432.CCR-12-2974. Epub 2012 Nov 20. No abstract available.

35.

Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Mathers JC, Movahedi M, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans G, Maher ER, Bertario L, Bisgaard ML, Dunlop M, Ho JW, Hodgson S, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen H, Gerdes AM, Barker G, Crawford G, Elliott F, Pylvanainen K, Wijnen J, Fodde R, Lynch H, Bishop DT, Burn J; CAPP2 Investigators.

Lancet Oncol. 2012 Dec;13(12):1242-9. doi: 10.1016/S1470-2045(12)70475-8. Epub 2012 Nov 7.

36.

Response to P. Autier and M. Boniol regarding our article--Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom.

Elliott F, Barrett JH, Timothy Bishop D, Newton-Bishop JA.

Int J Cancer. 2013 Apr 15;132(8):1960-1. doi: 10.1002/ijc.27847. Epub 2012 Oct 12. No abstract available.

37.

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.

Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, Hall J, Landi S, Bishop DT, Kiltie AE.

Carcinogenesis. 2012 Mar;33(3):581-6. doi: 10.1093/carcin/bgr300. Epub 2011 Dec 12.

38.

Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.

Storr SJ, Safuan S, Mitra A, Elliott F, Walker C, Vasko MJ, Ho B, Cook M, Mohammed RA, Patel PM, Ellis IO, Newton-Bishop JA, Martin SG.

Mod Pathol. 2012 Apr;25(4):493-504. doi: 10.1038/modpathol.2011.182. Epub 2011 Nov 11.

39.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JW, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT; CAPP2 Investigators.

Lancet. 2011 Dec 17;378(9809):2081-7. doi: 10.1016/S0140-6736(11)61049-0. Epub 2011 Oct 27.

40.

The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate.

Davies JR, Chang YM, Snowden H, Chan M, Leake S, Karpavicius B, Haynes S, Kukalizch K, Randerson-Moor J, Elliott F, Barth J, Kanetsky PA, Harland M, Bishop DT, Barrett JH, Newton-Bishop JA.

Cancer Causes Control. 2011 Oct;22(10):1471-82. doi: 10.1007/s10552-011-9827-3. Epub 2011 Aug 19.

41.

Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom.

Elliott F, Suppa M, Chan M, Leake S, Karpavicius B, Haynes S, Barrett JH, Bishop DT, Newton-Bishop JA.

Int J Cancer. 2012 Jun 15;130(12):3011-3. doi: 10.1002/ijc.26347. Epub 2011 Aug 30. No abstract available.

42.

The determinants of periorbital skin ageing in participants of a melanoma case-control study in the U.K.

Suppa M, Elliott F, Mikeljevic JS, Mukasa Y, Chan M, Leake S, Karpavicius B, Haynes S, Bakker E, Peris K, Barrett JH, Bishop DT, Newton Bishop JA.

Br J Dermatol. 2011 Nov;165(5):1011-21. doi: 10.1111/j.1365-2133.2011.10536.x.

43.

European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA, Grotenhuis AJ, Verhaegh GW, Hulsbergen-van de Kaa CA, Besenbacher S, Gudbjartsson D, Stacey SN, Gudmundsson J, Johannsdottir H, Bjarnason H, Zanon C, Helgadottir H, Jonasson JG, Tryggvadottir L, Jonsson E, Geirsson G, Nikulasson S, Petursdottir V, Bishop DT, Chung-Sak S, Choudhury A, Elliott F, Barrett JH, Knowles MA, de Verdier PJ, Ryk C, Lindblom A, Rudnai P, Gurzau E, Koppova K, Vineis P, Polidoro S, Guarrera S, Sacerdote C, Panadero A, Sanz-Velez JI, Sanchez M, Valdivia G, Garcia-Prats MD, Hengstler JG, Selinski S, Gerullis H, Ovsiannikov D, Khezri A, Aminsharifi A, Malekzadeh M, van den Berg LH, Ophoff RA, Veldink JH, Zeegers MP, Kellen E, Fostinelli J, Andreoli D, Arici C, Porru S, Buntinx F, Ghaderi A, Golka K, Mayordomo JI, Matullo G, Kumar R, Steineck G, Kiltie AE, Kong A, Thorsteinsdottir U, Stefansson K, Kiemeney LA.

Hum Mol Genet. 2011 Nov 1;20(21):4268-81. doi: 10.1093/hmg/ddr303. Epub 2011 Jul 12.

44.

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.

Qiao B, Scott GB, Elliott F, Vaslin L, Bentley J, Hall J, Bishop DT, Knowles MA, Kiltie AE.

BMC Med Genet. 2011 Jun 20;12:84. doi: 10.1186/1471-2350-12-84.

45.

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis.

Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R, Maher ER, Möslein G, Vasen HF, Coaker J, Phillips RK, Bülow S, Mathers JC; International CAPP consortium.

Cancer Prev Res (Phila). 2011 May;4(5):655-65. doi: 10.1158/1940-6207.CAPR-11-0106.

46.

In vitro functional effects of XPC gene rare variants from bladder cancer patients.

Qiao B, Ansari AH, Scott GB, Sak SC, Chambers PA, Elliott F, Teo MT, Bentley J, Churchman M, Hall J, Taylor CF, Bishop TD, Knowles MA, Kiltie AE.

Carcinogenesis. 2011 Apr;32(4):516-21. doi: 10.1093/carcin/bgr005. Epub 2011 Jan 27.

47.

Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate.

Newton-Bishop JA, Chang YM, Elliott F, Chan M, Leake S, Karpavicius B, Haynes S, Fitzgibbon E, Kukalizch K, Randerson-Moor J, Elder DE, Bishop DT, Barrett JH.

Eur J Cancer. 2011 Mar;47(5):732-41. doi: 10.1016/j.ejca.2010.10.008.

48.

Melanoma sentinel node biopsy and prediction models for relapse and overall survival.

Mitra A, Conway C, Walker C, Cook M, Powell B, Lobo S, Chan M, Kissin M, Layer G, Smallwood J, Ottensmeier C, Stanley P, Peach H, Chong H, Elliott F, Iles MM, Nsengimana J, Barrett JH, Bishop DT, Newton-Bishop JA.

Br J Cancer. 2010 Oct 12;103(8):1229-36. doi: 10.1038/sj.bjc.6605849. Epub 2010 Sep 21.

49.

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

Choudhury A, Nelson LD, Teo MT, Chilka S, Bhattarai S, Johnston CF, Elliott F, Lowery J, Taylor CF, Churchman M, Bentley J, Knowles MA, Harnden P, Bristow RG, Bishop DT, Kiltie AE.

Cancer Res. 2010 Sep 15;70(18):7017-26. doi: 10.1158/0008-5472.CAN-10-1202.

50.

Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.

Newton-Bishop JA, Chang YM, Iles MM, Taylor JC, Bakker B, Chan M, Leake S, Karpavicius B, Haynes S, Fitzgibbon E, Elliott F, Kanetsky PA, Harland M, Barrett JH, Bishop DT.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2043-54. doi: 10.1158/1055-9965.EPI-10-0233. Epub 2010 Jul 20. Erratum in: Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1049.

Supplemental Content

Loading ...
Support Center